Skip to main content

Advertisement

Articles

Page 29 of 35

  1. Aspirin has been recommended for the prevention of major adverse cardiovascular events (MACE, composite of non-fatal myocardial infarction, non-fatal stroke, and cardiovascular death) in diabetic patients with...

    Authors: Sonia Butalia, Alexander A Leung, William A Ghali and Doreen M Rabi

    Citation: Cardiovascular Diabetology 2011 10:25

    Content type: Review

    Published on:

  2. Hypertension, diabetes and obesity are not isolated findings, but a series of interacting interactive physiologic derangements. Taking into account genetic background and lifestyle behavior, AI (autonomic imba...

    Authors: Leandro Boer-Martins, Valéria N Figueiredo, Caroline Demacq, Luiz C Martins, Fernanda Consolin-Colombo, Márcio J Figueiredo, Fernando PS Cannavan and Heitor Moreno Jr

    Citation: Cardiovascular Diabetology 2011 10:24

    Content type: Original investigation

    Published on:

  3. Increased plasma plasminogen activator inhibitor-1 (PAI-1) activity and decreased tissue plasminogen activator (tPA) activity could be considered a true component of the metabolic syndrome (MetS) associated wi...

    Authors: Zaid Al-Hamodi, Ikram S Ismail, Riyadh Saif-Ali, Khaled A Ahmed and Sekaran Muniandy

    Citation: Cardiovascular Diabetology 2011 10:23

    Content type: Original investigation

    Published on:

  4. It is important for patients that treatments for diabetes not increase cardiovascular (CV) risk. The objective of this analysis was to examine retrospectively the CV safety of exenatide BID, a GLP-1 receptor a...

    Authors: Robert Ratner, Jenny Han, Dawn Nicewarner, Irina Yushmanova, Byron J Hoogwerf and Larry Shen

    Citation: Cardiovascular Diabetology 2011 10:22

    Content type: Original investigation

    Published on:

  5. Although European guidelines advise oral glucose tolerance test (OGTT) in patients with acute myocardial infarction (AMI) before or shortly after hospital discharge, data supporting this recommendation are inc...

    Authors: Agata Bronisz, Marek Kozinski, Przemyslaw Magielski, Tomasz Fabiszak, Joanna Gierach, Iwona Swiatkiewicz, Adam Sukiennik, Aldona Kubica, Marek Bronisz, Zofia Grabczewska, Anna Sinkiewicz, Roman Junik and Jacek Kubica

    Citation: Cardiovascular Diabetology 2011 10:21

    Content type: Original investigation

    Published on:

  6. Apolipoprotein B100 (apoB) is a superior indicator of CV risk than total or LDL-C. Non-HDL-C represents a simple surrogate for apoB in hypertriglyceridemic and/or T2DM patients. ApoB and non-HDL-C show high corre...

    Authors: Michel P Hermans, Frank M Sacks, Sylvie A Ahn and Michel F Rousseau

    Citation: Cardiovascular Diabetology 2011 10:20

    Content type: Original investigation

    Published on:

  7. Glucose variability is one of components of the dysglycemia in diabetes and may play an important role in development of diabetic vascular complications. The objective of this study was to assess the relations...

    Authors: Gong Su, Shuhua Mi, Hong Tao, Zhao Li, Hongxia Yang, Hong Zheng, Yun Zhou and Changsheng Ma

    Citation: Cardiovascular Diabetology 2011 10:19

    Content type: Original investigation

    Published on:

  8. Type 2 diabetes (T2D) is strongly associated with cardiovascular risk and requires medications that improve glycemic control and other cardiovascular risk factors. The authors aimed to assess the relative effe...

    Authors: Ángel Rodríguez, Jesús Reviriego, Vasilios Karamanos, Francisco J del Cañizo, Nikolaos Vlachogiannis and Vangelis Drossinos

    Citation: Cardiovascular Diabetology 2011 10:18

    Content type: Original investigation

    Published on:

  9. The biological mechanisms in the association between the metabolic syndrome (MS) and various biomarkers, such as 25-hydroxyvitamin D (vit D) and magnesium, are not fully understood. Several of the proposed pre...

    Authors: Jo Røislien, Ben Van Calster and Jøran Hjelmesæth

    Citation: Cardiovascular Diabetology 2011 10:17

    Content type: Original investigation

    Published on:

  10. Elevated plasma levels of asymmetric dimethylarginine (ADMA) has been reported to be associated with insulin resistance and micro/macrovascular diabetic complications, and may predict cardiovascular events in ...

    Authors: Tse-Min Lu, Shing-Jong Lin, Ming-Wei Lin, Chiao-Po Hsu and Ming-Yi Chung

    Citation: Cardiovascular Diabetology 2011 10:16

    Content type: Original investigation

    Published on:

  11. To assess heart failure therapies in diabetic patients with preserved as compared to impaired systolic ventricular function.

    Authors: Frank Edelmann, Rolf Wachter, Hans-Dirk Düngen, Stefan Störk, Annette Richter, Raoul Stahrenberg, Till Neumann, Claus Lüers, Christiane E Angermann, Felix Mehrhof, Götz Gelbrich and Burkert Pieske

    Citation: Cardiovascular Diabetology 2011 10:15

    Content type: Original investigation

    Published on:

  12. Adiponectin has insulin-sensitizing and anti-atherosclerotic effects, partly mediated through its action on monocytes. We aimed to determine adiponectin levels and expression of its receptors (AdipoR1 and Adip...

    Authors: Anastasios Kollias, Panayoula C Tsiotra, Ignatios Ikonomidis, Eirini Maratou, Panayota Mitrou, Erifyli Kyriazi, Eleni Boutati, John Lekakis, Theofanis Economopoulos, Dimitrios T Kremastinos, George Dimitriadis and Sotirios A Raptis

    Citation: Cardiovascular Diabetology 2011 10:14

    Content type: Original investigation

    Published on:

  13. Diabetes mellitus has emerged as one of the main alarms to human health in the 21st century. Pronounced changes in the human environment, behavior and lifestyle have accompanied globalization, which resulted i...

    Authors: Edite Teixeira-Lemos, Sara Nunes, Frederico Teixeira and Flávio Reis

    Citation: Cardiovascular Diabetology 2011 10:12

    Content type: Review

    Published on:

  14. The peroxisome proliferator-activated receptor-γ (PPARγ) agonist rosiglitazone has been suggested to exert cardiovascular protection through the improvement of lipid metabolism, anti-inflammation, anti-prolife...

    Authors: Liqun Ren, Naifeng Liu, Hong Zhi, Yingjuan Li, Yanzhi Li, Rining Tang and Zulong Sheng

    Citation: Cardiovascular Diabetology 2011 10:10

    Content type: Original investigation

    Published on:

  15. Given the elevated risk of cardiovascular events and the higher prevalence of silent coronary artery disease (CAD) in diabetic versus non-diabetic patients, the need to screen asymptomatic diabetic patients fo...

    Authors: Cristina Hernández, Jaume Candell-Riera, Andreea Ciudin, Gemma Francisco, Santiago Aguadé-Bruix and Rafael Simó

    Citation: Cardiovascular Diabetology 2011 10:9

    Content type: Original investigation

    Published on:

  16. Adiponectin and resistin are adipokines which modulate insulin action, energy, glucose and lipid homeostasis. Meta-analyses showed that hypoadiponectinemia and hyperresistinemia are strongly associated with in...

    Authors: Cia-Hin Lau and Sekaran Muniandy

    Citation: Cardiovascular Diabetology 2011 10:8

    Content type: Original investigation

    Published on:

  17. Glycemic control and management of dyslipidemia to reduce cardiovascular risk are major therapeutic goals in individuals with type 2 diabetes mellitus (T2DM). This study was performed to evaluate the effects o...

    Authors: Barbara C Hansen, Xenia T Tigno, Agnes Bénardeau, Markus Meyer, Elena Sebokova and Jacques Mizrahi

    Citation: Cardiovascular Diabetology 2011 10:7

    Content type: Original investigation

    Published on:

  18. Glucagon-like peptide-1 (GLP-1) is a hormone predominately synthesized and secreted by intestinal L-cells. GLP-1 modulates multiple cellular functions and its receptor agonists are now used clinically for diab...

    Authors: Yong-Fu Xiao, Alena Nikolskaya, Deborah A Jaye and Daniel C Sigg

    Citation: Cardiovascular Diabetology 2011 10:6

    Content type: Original investigation

    Published on:

  19. Type 2 diabetes is a well-established risk factor for cardiovascular disease and is common among patients with acute myocardial infarction (MI). The extent to which patients with first-time MI develop diabetes...

    Authors: Mette L Norgaard, Charlotte Andersson, Peter Riis Hansen, Søren S Andersen, Allan Vaag, Tina K Schramm, Fredrik Folke, Lars Køber, Christian Torp-Pedersen and Gunnar H Gislason

    Citation: Cardiovascular Diabetology 2011 10:5

    Content type: Original investigation

    Published on:

  20. Diabetic cardiomyopathy, characterized by myocardial structural and functional changes, is a specific cardiomyopathy develops in patients with diabetes mellitus. The present study was to investigate the role o...

    Authors: Dongdong Sun, Min Shen, Jiayi Li, Weijie Li, Yingmei Zhang, Li Zhao, Zheng Zhang, Yuan Yuan, Haichang Wang and Feng Cao

    Citation: Cardiovascular Diabetology 2011 10:4

    Content type: Original investigation

    Published on:

  21. We examined the relationship between the intima-media thickness of the common carotid artery (CCA-IMT) and arterial stiffness, assessed by pulse wave velocity (PWV), the ambulatory arterial stiffness index (AA...

    Authors: Manuel Ángel Gómez-Marcos, José Ignacio Recio-Rodríguez, María Carmen Patino-Alonso, Cristina Agudo-Conde, Leticia Gómez-Sánchez, Emiliano Rodríguez-Sánchez, Carlos Martín-Cantera and Luís García-Ortiz

    Citation: Cardiovascular Diabetology 2011 10:3

    Content type: Original investigation

    Published on:

  22. Disorders of endocrine substances in epicardial adipose tissue are known causes of coronary artery disease (CAD). Adiponectin is associated with cardiovascular disease. However, expression of adiponectin in ep...

    Authors: Yuan Zhou, Yutao Wei, Lei Wang, Xianguo Wang, Xinling Du, Zongquan Sun, Nianguo Dong and Xinzhong Chen

    Citation: Cardiovascular Diabetology 2011 10:2

    Content type: Original investigation

    Published on:

  23. To estimate the incidence of complications, life expectancy and diabetes related mortality in the Mexican diabetic population over the next two decades using data from a nation-wide, population based survey an...

    Authors: Nancy Reynoso-Noverón, Roopa Mehta, Paloma Almeda-Valdes, Rosalba Rojas-Martinez, Salvador Villalpando, Mauricio Hernández-Ávila and Carlos A Aguilar-Salinas

    Citation: Cardiovascular Diabetology 2011 10:1

    Content type: Original investigation

    Published on:

  24. Diabetes mellitus counts as a major risk factor for developing atherosclerosis. The activation of protein kinase C (PKC) is commonly known to take a pivotal part in the pathogenesis of atherosclerosis, though ...

    Authors: Dieter Paul Hoyer, Yüksel Korkmaz, Sabine Grönke, Klaus Addicks, Nina Wettschureck, Stefan Offermanns and Hannes Reuter

    Citation: Cardiovascular Diabetology 2010 9:93

    Content type: Original investigation

    Published on:

  25. There is debate as to whether the association between C-reactive protein (CRP) and insulin resistance is independent of body fatness, particularly central obesity. Therefore, the association among CRP, insulin...

    Authors: Bin Lu, Yehong Yang, Zhihong Yang, Xiaocheng Feng, Xuanchun Wang, Zhaoyun Zhang and Renming Hu

    Citation: Cardiovascular Diabetology 2010 9:92

    Content type: Original investigation

    Published on:

  26. Plaque morphology directly correlates with risk of embolism and the recently developed dual-source computed tomography angiography (DSCTA) may help to detect plaques more precisely. The aim of our study was to...

    Authors: Ci He, Zhi-gang Yang, Zhi-gang Chu, Zhi-hui Dong, Heng Shao, Wen Deng, Jing Chen, Li-qing Peng, Si-shi Tang and Jia-he Xiao

    Citation: Cardiovascular Diabetology 2010 9:91

    Content type: Original investigation

    Published on:

  27. Endothelial inflammatory responses mediated by Toll-like receptors (TLRs), particularly TLR2 and TLR4, play an important role in atherogenesis. While Type 1 diabetes (T1D) promotes the development and progress...

    Authors: Jilin Li, Chunhua Jin, Joseph C Cleveland Jr, Lihua Ao, Dingli Xu, David A Fullerton and Xianzhong Meng

    Citation: Cardiovascular Diabetology 2010 9:90

    Content type: Original investigation

    Published on:

  28. The aim of the present study was to verify whether BNP might detect pre-clinical diastolic dysfunction (LVDD) in type-2 diabetic patients.

    Authors: Silvio Romano, Michele Di Mauro, Simona Fratini, Leonello Guarracini, Fabrizio Guarracini, Gianfranco Poccia and Maria Penco

    Citation: Cardiovascular Diabetology 2010 9:89

    Content type: Original investigation

    Published on:

  29. T2DM is associated with atherogenic dyslipidemia (AD), defined as decreased HDL-C plus raised triglycerides (TG). AD confers increased risk for CAD, even when LDL-C is at target. AD is rarely assessed due to l...

    Authors: Michel P Hermans, Sylvie A Ahn and Michel F Rousseau

    Citation: Cardiovascular Diabetology 2010 9:88

    Content type: Original investigation

    Published on:

  30. Metabolic syndrome (MetS) is associated with an increased risk of major cardiovascular events. Increased high-sensitivity C-reactive protein (hsCRP) levels are associated with MetS and its components. Changes ...

    Authors: Ryuichi Kawamoto, Yasuharu Tabara, Katsuhiko Kohara, Tetsuro Miki, Tomo Kusunoki, Shuzo Takayama, Masanori Abe, Tateaki Katoh and Nobuyuki Ohtsuka

    Citation: Cardiovascular Diabetology 2010 9:87

    Content type: Original investigation

    Published on:

  31. Low grade inflammation is of pathogenic importance in atherosclerosis and in the development of cardiovascular disease (CVD) and type 2 diabetes (T2D). Matrix GLA protein (MGP), an inhibitor of medial calcific...

    Authors: Stine B Thomsen, Camilla N Rathcke, Bo Zerahn and Henrik Vestergaard

    Citation: Cardiovascular Diabetology 2010 9:86

    Content type: Original investigation

    Published on:

  32. Insulin resistance (IR) has been associated with cardiovascular diseases (CVD). Heart rate variability (HRV), an index of cardiac autonomic modulation (CAM), is also associated with CVD mortality and CVD morbi...

    Authors: Sol M Rodríguez-Colón, Xian Li, Michele L Shaffer, Fan He, Edward O Bixler, Alexandros N Vgontzas, Jianwen Cai and Duanping Liao

    Citation: Cardiovascular Diabetology 2010 9:85

    Content type: Original investigation

    Published on:

  33. To investigate whether the known diabetes mellitus (KDM) or newly diagnosed diabetes mellitus (NDM) could be regarded as a coronary heart disease (CHD) risk equivalent among a relatively young Middle East popu...

    Authors: Farzad Hadaegh, Nooshin Fahimfar, Davood Khalili, Farhad Sheikholeslami and Fereidoun Azizi

    Citation: Cardiovascular Diabetology 2010 9:84

    Content type: Original investigation

    Published on:

  34. Notwithstanding previous studies supporting independent associations between obstructive sleep apnea (OSA) and prevalence of diabetes, the underlying pathogenesis of impaired glucose regulation in OSA remains ...

    Authors: Maria Pallayova, Kimberley E Steele, Thomas H Magnuson, Michael A Schweitzer, Nathan R Hill, Shannon Bevans-Fonti and Alan R Schwartz

    Citation: Cardiovascular Diabetology 2010 9:83

    Content type: Original investigation

    Published on:

  35. Azelnidipine (AZL), a long-acting dihydropyridine-based calcium antagonist, has been recently approved and used for treating ischemic heart disease and cardiac remodeling after myocardial infarction, however, ...

    Authors: Vasundhara Kain, Sandeep Kumar, Amrutesh S Puranik and Sandhya L Sitasawad

    Citation: Cardiovascular Diabetology 2010 9:82

    Content type: Original investigation

    Published on:

  36. Higher walking levels lead to lower mortality in type 2 diabetes, but inclement weather may reduce walking. In this patient population, we conducted a longitudinal cohort study to objectively quantify seasonal...

    Authors: Kaberi Dasgupta, Lawrence Joseph, Louise Pilote, Ian Strachan, Ron J Sigal and Cathy Chan

    Citation: Cardiovascular Diabetology 2010 9:81

    Content type: Original investigation

    Published on:

  37. Diabetics have high prevalence of subclinical coronary artery disease (CAD) with typical characteristics (diffuse disease, large calcifications). Although 64-slice multidetector computed tomography (MDCT) coro...

    Authors: Daniele Andreini, Gianluca Pontone, Antonio L Bartorelli, Piergiuseppe Agostoni, Saima Mushtaq, Laura Antonioli, Sarah Cortinovis, Mauro Canestrari, Andrea Annoni, Giovanni Ballerini, Cesare Fiorentini and Mauro Pepi

    Citation: Cardiovascular Diabetology 2010 9:80

    Content type: Original investigation

    Published on:

  38. Recent studies revealed that glucokinase regulatory protein (GCKR) variants (rs780094 and rs1260326) are associated with serum triglycerides and plasma glucose levels. Here we analyzed primarily the associatio...

    Authors: Márton Mohás, Péter Kisfali, Luca Járomi, Anita Maász, Eszter Fehér, Veronika Csöngei, Noémi Polgár, Enikő Sáfrány, Judit Cseh, Katalin Sümegi, Katalin Hetyésy, István Wittmann and Béla Melegh

    Citation: Cardiovascular Diabetology 2010 9:79

    Content type: Original investigation

    Published on:

  39. The various autonomic control systems lead to characteristic changes in heart rate (HR) and blood pressure (BP) during acute hemorrhage. However, cardiovascular autonomic neuropathy due to diabetes mellitus ma...

    Authors: Aiji Boku, Mitsutaka Sugimura, Yoshinari Morimoto, Hiroshi Hanamoto and Hitoshi Niwa

    Citation: Cardiovascular Diabetology 2010 9:78

    Content type: Original investigation

    Published on:

  40. Dyslipidaemia is an important but modifiable risk factor of cardiovascular disease (CVD) in type 2 diabetes. Yet, the effectiveness of lipid regulating drugs in Asians is lacking. We examined the effects of li...

    Authors: Rose ZW Ting, Xilin Yang, Linda WL Yu, Andrea OY Luk, Alice PS Kong, Peter CY Tong, Wing-Yee So, Juliana CN Chan and Ronald CW Ma

    Citation: Cardiovascular Diabetology 2010 9:77

    Content type: Original investigation

    Published on:

  41. Accumulating evidence suggests glucagon-like peptide-1 (GLP-1) exerts cardioprotective effects in animal models of myocardial infarction (MI). We hypothesized that chronic treatment with GLP-1 or the exenatide...

    Authors: Que Liu, Christen Anderson, Anatoly Broyde, Clara Polizzi, Rayne Fernandez, Alain Baron and David G Parkes

    Citation: Cardiovascular Diabetology 2010 9:76

    Content type: Original investigation

    Published on:

  42. Diabetes mellitus (DM) and impaired glucose tolerance (IGT) are risk factors for acute myocardial infarction (AMI). However, it is unknown whether hyperglycemic state is associated with increased major adverse...

    Authors: Shuichi Kitada, Yoritaka Otsuka, Nobuaki Kokubu, Yoichiro Kasahara, Yu Kataoka, Teruo Noguchi, Yoichi Goto, Genjirou Kimura and Hiroshi Nonogi

    Citation: Cardiovascular Diabetology 2010 9:75

    Content type: Original investigation

    Published on:

  43. Coronary artery disease (CAD) is a common and severe complication of type 2 diabetes mellitus (DM). The aim of this study is to identify the features of CAD in diabetic patients using coronary CT angiography (...

    Authors: Zhi-gang Chu, Zhi-gang Yang, Zhi-hui Dong, Zhi-yu Zhu, Li-qing Peng, Heng Shao, Ci He, Wen Deng, Si-shi Tang and Jing Chen

    Citation: Cardiovascular Diabetology 2010 9:74

    Content type: Original investigation

    Published on:

  44. Insulin resistance is associated with a proinflammatory state that promotes the development of complications such as type 2 diabetes mellitus (T2DM) and atherosclerosis. The metabolic stimuli that initiate and...

    Authors: Robert C Bunn, Gael E Cockrell, Yang Ou, Kathryn M Thrailkill, Charles K Lumpkin Jr and John L Fowlkes

    Citation: Cardiovascular Diabetology 2010 9:73

    Content type: Original investigation

    Published on:

  45. Informations about the effects of intense exercise training on diabetes-induced myocardial dysfunctions are lacking. We have examined the effects of intense exercise training on the cardiac function of diabeti...

    Authors: Solène Le Douairon Lahaye, Arlette Gratas-Delamarche, Ludivine Malardé, Sophie Vincent, Mohamed Sami Zguira, Sophie Lemoine Morel, Paul Delamarche, Hassane Zouhal, François Carré and Françoise Rannou Bekono

    Citation: Cardiovascular Diabetology 2010 9:72

    Content type: Original investigation

    Published on:

  46. Baboons (Papio hamadryas Sp.) develop features of the cardiometabolic syndrome and represent a clinically-relevant animal model in which to study the aetiology of the disorder. To further evaluate the baboon as a...

    Authors: Paul B Higgins, Raul A Bastarrachea, Juan Carlos Lopez-Alvarenga, Maggie Garcia-Forey, J Michael Proffitt, V Saroja Voruganti, M Elizabeth Tejero, Vicki Mattern, Karin Haack, Robert E Shade, Shelley A Cole and Anthony G Comuzzie

    Citation: Cardiovascular Diabetology 2010 9:71

    Content type: Original investigation

    Published on:

  47. The aim of the present cross-sectional study was to assess possible associations between osteopontin (OPN), and thrombin-cleaved (N-half) OPN, and nephropathy and coronary artery disease (CAD) in patients with...

    Authors: Xiaoxiang Yan, Motoaki Sano, Lin Lu, Wei Wang, Qi Zhang, Ruiyan Zhang, Lingjie Wang, Qiujing Chen, Keiichi Fukuda and Weifeng Shen

    Citation: Cardiovascular Diabetology 2010 9:70

    Content type: Original investigation

    Published on:

  48. Epidemiological evidence suggests that fibrinogen and CRP are associated with coronary heart disease risk. High CRP in Indigenous Australians has been reported in previous studies including our 'Diabetes and R...

    Authors: Louise J Maple-Brown, Joan Cunningham, Nirjhar Nandi, Allison Hodge and Kerin O'Dea

    Citation: Cardiovascular Diabetology 2010 9:69

    Content type: Original investigation

    Published on:

Annual Journal Metrics

Advertisement